GRCE · NASDAQ · Biotechnology

Grace Therapeutics (GRCE)

Developing alternative-delivery therapies from established drugs.

$2.14
Pre-market0.00 (0.00%)
At close$2.14(+1.90%)

Breakdown13F · 13D/G · Form 4

Institutions36 holders · as of Mar 31, 202626.20%4.26M shares
Insiders1 holder · as of May 8, 20258.13%1.32M shares
Strategic holders2 holders · as of Aug 19, 202627.51%4.48M shares
Otherremainder38.16%6.21M shares

16.27M company shares as of Sep 2, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (21.04M in the company's Sep 3, 2026 report, 16.27M elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Opaleye Management Inc.Strategic10 percent owner
16.96%2.76MForm 4filed Aug 19, 2026
ADAR1 Capital Management, LLCStrategic
10.55%1.72M13Gfiled May 15, 2026
Orin HirschmanInsider
8.13%1.32M13Gfiled May 8, 2025
Cerity Partners LLCInstitution
5.22%849,05513Fas of Mar 31, 2026
Eversept Partners, LPInstitution
4.65%756,60013Fas of Mar 31, 2026
Nantahala Capital Management, LLCInstitution
4.47%728,20313Fas of Mar 31, 2026
Bank of America Corp /DE/Institution
3.04%494,72313Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution
2.47%401,65613Fas of Mar 31, 2026
Renaissance Technologies LLCInstitution
1.50%243,91013Fas of Mar 31, 2026
Jane Street Group, LLCInstitution
1.03%167,09713Fas of Mar 31, 2026
Citadel Advisors LLCInstitution
0.61%98,74213Fas of Mar 31, 2026
Marshall Wace, LLPInstitution
0.56%91,41613Fas of Mar 31, 2026
Connective Capital Management, LLCInstitution
0.52%84,54913Fas of Mar 31, 2026
Quadrature Capital LtdInstitution
0.41%66,82213Fas of Mar 31, 2026
XTX Topco LtdInstitution
0.39%63,09413Fas of Mar 31, 2026
Birchview Capital, LPInstitution
0.31%50,00013Fas of Mar 31, 2026
Diametric Capital, LPInstitution
0.24%39,79613Fas of Mar 31, 2026
Pale Fire Capital SEInstitution
0.23%37,76213Fas of Mar 31, 2026
UBS Group AGInstitution
0.16%26,30113Fas of Mar 31, 2026
Kestra Private Wealth Services, LLCInstitution
0.08%13,00013Fas of Mar 31, 2026
Prelude Capital Management, LLCInstitution
0.06%10,07413Fas of Mar 31, 2026
Oppenheimer & Co IncInstitution
0.06%10,00013Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution
0.05%8,75013Fas of Mar 31, 2026
BNP Paribas Arbitrage, SNCInstitution
0.04%7,10013Fas of Mar 31, 2026
Group One Trading, L.P.Institution
0.03%5,00013Fas of Mar 31, 2026

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

36 holders · 4.26M shares · 19 new positions · 25 increased · 4 reduced · 6 closed

HolderShares% outstandingChg q/qFiled
Cerity Partners LLC849.1K5.22%+426.3KMay 15, 2026
Eversept Partners, LP756.6K4.65%+756.6KnewMay 15, 2026
Nantahala Capital Management, LLC728.2K4.47%−450.0KMay 15, 2026
Bank of America Corp /DE/494.7K3.04%+25May 18, 2026
Vanguard Capital Management LLC401.7K2.47%+401.7KnewMay 15, 2026
Renaissance Technologies LLC243.9K1.50%+114.1KMay 14, 2026
Jane Street Group, LLC167.1K1.03%+167.1KnewMay 12, 2026
Citadel Advisors LLC98.7K0.61%+56.4KMay 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Opaleye Management Inc.13.07%2.75M13GAug 7, 2026
Nantahala Capital Management, LLC9.99%1.59M13GFeb 13, 2026
ADAR1 Capital Management, LLC9.90%1.72M13GMay 15, 2026
Hirschman Orin9.90%1.32M13GMay 8, 2025

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 14, 2026
Opaleye Management Inc.10 percent owner
Purchase11,608$2.092,760,000

CongressHouse and Senate disclosures

Not reported.